TUESDAY, May 30, 2023 (HealthDay News) — Some short men really struggle with their lack of height, feeling that they are both literally and figuratively looked down upon by others. That’s why an increasing number of height-challenged men are turning to limb-lengthening surgery — an expensive, potentially painful, months-long procedureContinue Reading

WEDNESDAY, May 17, 2023 (HealthDay News) — When young men pack on excess weight during their teens and 20s, they may inadvertently drive up their risk for prostate cancer later on. The concern stems from new research that examined several decades’ worth of weight fluctuations and prostate cancer rates amongContinue Reading

TUESDAY, May 16, 2023 (HealthDay News) — Lured by promises of bigger muscles and better performance on the field, many athletes and bodybuilders turn to anabolic steroids despite their well-known side effects, including increased risk for heart disease and mood issues. Now, two new studies show these harms may persistContinue Reading

TUESDAY, May 2, 2023 (HealthDay News) — The U.S. Food and Drug Administration is once again warning consumers to avoid muscle-building “supplements” that are anything but a safe alternative to steroids. In an advisory sent out last week, the agency said it continues to receive reports of serious side effectsContinue Reading

TUESDAY, April 4, 2023 (HealthDay News) — Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates. Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced “active surveillance,” in which their diseaseContinue Reading

TUESDAY, March 21, 2023 (HealthDay News) — An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said it can’t keep up with demand for the medication, known as Pluvicto.Continue Reading

THURSDAY, March 2, 2023 (HealthDay News) — Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports. The procedure, called prostate artery embolization (PAE), dramatically improved urinary symptoms in patients without having any effectContinue Reading